Rifamycin Antibacterial [EPC]

Rifamycin Antibacterial [EPC] was reported 36211 times

Drugs of the Rifamycin Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PORTAL SHUNT PROCEDURE 26 0.3714
1 TYPE 2 LEPRA REACTION 61 0.3262
2 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 100 0.2985
3 GASTROINTESTINAL BACTERIAL OVERGROWTH 114 0.1900
4 ATYPICAL MYCOBACTERIUM TEST POSITIVE 18 0.1856
5 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 32 0.1758
6 AMMONIA INCREASED 863 0.1690
7 AMMONIA ABNORMAL 60 0.1489
8 GASTROINTESTINAL MICROORGANISM OVERGROWTH 50 0.1420
9 ANTICOAGULATION DRUG LEVEL DECREASED 17 0.1405
10 MYCOBACTERIUM AVIUM COMPLEX INFECTION 301 0.1120
11 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 29 0.1070
12 PARADOXICAL DRUG REACTION 392 0.1064
13 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0995
14 BILE ACIDS INCREASED 17 0.0960
15 HEPATIC ENCEPHALOPATHY 894 0.0957
16 OLIGOARTHRITIS 19 0.0955
17 PARACENTESIS 57 0.0927
18 CIRRHOSIS ALCOHOLIC 42 0.0917
19 MYCOBACTERIUM HAEMOPHILUM INFECTION 25 0.0874
20 HYPOPROTHROMBINAEMIA 23 0.0764
21 OVERGROWTH BACTERIAL 20 0.0743
22 INABILITY TO AFFORD MEDICATION 715 0.0719
23 PORTAL HYPERTENSIVE GASTROPATHY 38 0.0674
24 CHOROIDITIS 23 0.0615
25 MYCOBACTERIAL INFECTION 103 0.0597
26 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 27 0.0578
27 LIVER TRANSPLANT 210 0.0577
28 CARDIAC VALVE VEGETATION 27 0.0556
29 MENINGITIS TUBERCULOUS 31 0.0555
30 INSURANCE ISSUE 742 0.0485
31 PANCREATITIS HAEMORRHAGIC 22 0.0474
32 ABDOMINAL CAVITY DRAINAGE 19 0.0450
33 MYCOBACTERIUM ABSCESSUS INFECTION 32 0.0448
34 DISSEMINATED TUBERCULOSIS 112 0.0436
35 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 217 0.0435
36 ATYPICAL MYCOBACTERIAL INFECTION 57 0.0403
37 HEPATIC CIRRHOSIS 739 0.0393
38 PULMONARY CAVITATION 33 0.0379
39 VASCULAR PURPURA 52 0.0372
40 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 44 0.0367
41 JARISCH-HERXHEIMER REACTION 26 0.0365
42 VARICES OESOPHAGEAL 110 0.0363
43 HEPATORENAL SYNDROME 61 0.0361
44 NON-ALCOHOLIC STEATOHEPATITIS 36 0.0347
45 LATENT TUBERCULOSIS 67 0.0320
46 PNEUMATOSIS INTESTINALIS 90 0.0315
47 OPTIC NEUROPATHY 66 0.0312
48 OEDEMATOUS PANCREATITIS 17 0.0303
49 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 774 0.0301
50 LYMPH NODE TUBERCULOSIS 21 0.0282
51 OTOTOXICITY 50 0.0270
52 PULMONARY TUBERCULOSIS 111 0.0260
53 HOSPICE CARE 246 0.0249
54 ASTERIXIS 26 0.0244
55 INTRA-ABDOMINAL FLUID COLLECTION 43 0.0240
56 MULTIPLE-DRUG RESISTANCE 74 0.0238
57 OESOPHAGEAL VARICES HAEMORRHAGE 50 0.0230
58 OCULAR TOXICITY 24 0.0217
59 PORTAL HYPERTENSION 62 0.0201
60 LABELLED DRUG-DRUG INTERACTION ISSUE 29 0.0200
61 HEPATIC FAILURE 584 0.0194
62 DRUG RESISTANCE 497 0.0193
63 SYMPTOM RECURRENCE 114 0.0190
64 HYPERAMMONAEMIC ENCEPHALOPATHY 33 0.0190
65 HEPATIC HAEMORRHAGE 16 0.0186
66 THERAPY INTERRUPTED 1300 0.0182
67 EOSINOPHILIC PNEUMONIA 57 0.0181
68 TYPE IV HYPERSENSITIVITY REACTION 49 0.0179
69 MEGACOLON 27 0.0172
70 METHAEMOGLOBINAEMIA 39 0.0168
71 PSEUDOMEMBRANOUS COLITIS 37 0.0166
72 IMMUNE RECONSTITUTION SYNDROME 21 0.0163
73 DRUG SPECIFIC ANTIBODY 22 0.0161
74 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 38 0.0160
75 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 21 0.0159
76 FOCAL DYSCOGNITIVE SEIZURES 18 0.0158
77 DISEASE COMPLICATION 72 0.0157
78 CHOLESTATIC LIVER INJURY 34 0.0153
79 HIDRADENITIS 134 0.0147
80 ADRENOCORTICAL INSUFFICIENCY ACUTE 28 0.0143
81 HEPATIC CYTOLYSIS 181 0.0142
82 ASCITES 415 0.0141
83 RENAL TUBULAR INJURY 17 0.0140
84 HOSPITALISATION 2054 0.0134
85 DRUG LEVEL DECREASED 133 0.0131
86 HYPERAMMONAEMIA 65 0.0130
87 SPUTUM INCREASED 28 0.0129
88 EOSINOPHILIA 226 0.0129
89 CRYPTOCOCCOSIS 21 0.0129
90 LIVER DISORDER 571 0.0129
91 OESOPHAGEAL HAEMORRHAGE 17 0.0128
92 LINEAR IGA DISEASE 21 0.0126
93 PATHOGEN RESISTANCE 115 0.0126
94 DRUG-INDUCED LIVER INJURY 392 0.0125
95 DERMATITIS EXFOLIATIVE GENERALISED 43 0.0124
96 DISTRIBUTIVE SHOCK 28 0.0124
97 PRODUCT SUPPLY ISSUE 86 0.0120
98 GRANULOMA 41 0.0118
99 BRONCHIECTASIS 79 0.0117
100 RASH MORBILLIFORM 32 0.0115
101 INTERVERTEBRAL DISCITIS 21 0.0111
102 ACUTE HEPATIC FAILURE 151 0.0110
103 CLOSTRIDIUM TEST POSITIVE 24 0.0109
104 TRANSPLANT 25 0.0105
105 STAPHYLOCOCCAL BACTERAEMIA 45 0.0103
106 HYPERTRANSAMINASAEMIA 72 0.0103
107 PRODUCT DISTRIBUTION ISSUE 96 0.0103
108 HEPATOTOXICITY 225 0.0101
109 HYPOPROTEINAEMIA 19 0.0100
110 LYMPHADENITIS 24 0.0099
111 HYDROCEPHALUS 54 0.0099
112 FIXED ERUPTION 17 0.0099
113 RESPIRATORY SYMPTOM 28 0.0098
114 HEPATITIS CHOLESTATIC 58 0.0096
115 ENCEPHALOPATHY 236 0.0096
116 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 71 0.0095
117 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 31 0.0094
118 ENDOCARDITIS 48 0.0093
119 CUTANEOUS VASCULITIS 34 0.0093
120 VIROLOGIC FAILURE 50 0.0093
121 HYPERPARATHYROIDISM SECONDARY 23 0.0092
122 RENAL TUBULAR NECROSIS 90 0.0092
123 TUBULOINTERSTITIAL NEPHRITIS 169 0.0090
124 PREGNANCY WITH IMPLANT CONTRACEPTIVE 42 0.0089
125 NEPHROGENIC ANAEMIA 41 0.0088
126 TREATMENT NONCOMPLIANCE 484 0.0088
127 HEPATIC MASS 17 0.0088
128 MULTIPLE ORGAN DYSFUNCTION SYNDROME 248 0.0087
129 IMMUNE THROMBOCYTOPENIA 40 0.0087
130 HYPERVOLAEMIA 43 0.0087
131 HYPERBILIRUBINAEMIA 90 0.0087
132 LUNG CONSOLIDATION 24 0.0086
133 VASCULAR DEVICE INFECTION 38 0.0084
134 RASH MACULO-PAPULAR 186 0.0084
135 PORTAL VEIN THROMBOSIS 27 0.0083
136 DIABETES INSIPIDUS 20 0.0083
137 BRAIN ABSCESS 21 0.0083
138 OPTIC NEURITIS 75 0.0082
139 DRUG INTERACTION 1300 0.0082
140 IRRITABLE BOWEL SYNDROME 174 0.0081
141 PRODUCT SIZE ISSUE 43 0.0080
142 KLEBSIELLA INFECTION 40 0.0079
143 HEPATIC LESION 34 0.0079
144 FUNCTIONAL GASTROINTESTINAL DISORDER 27 0.0078
145 COAGULOPATHY 130 0.0078
146 HENOCH-SCHONLEIN PURPURA 17 0.0078
147 CLOSTRIDIUM DIFFICILE COLITIS 82 0.0077
148 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 415 0.0076
149 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 20 0.0075
150 THERAPY CESSATION 383 0.0075
151 DRUG LEVEL BELOW THERAPEUTIC 41 0.0074
152 HEPATIC CANCER 178 0.0074
153 HEPATOCELLULAR CARCINOMA 56 0.0074
154 SYNOVIAL CYST 34 0.0074
155 BILIRUBIN CONJUGATED INCREASED 17 0.0073
156 OCULAR ICTERUS 31 0.0071
157 IDIOPATHIC INTRACRANIAL HYPERTENSION 16 0.0071
158 HEPATIC NEOPLASM 23 0.0070
159 ABDOMINAL INFECTION 18 0.0070
160 HAEMOLYTIC ANAEMIA 63 0.0070
161 LICHENOID KERATOSIS 16 0.0070
162 SPLENOMEGALY 82 0.0070
163 METABOLIC ENCEPHALOPATHY 21 0.0070
164 REHABILITATION THERAPY 27 0.0070
165 SKIN NECROSIS 36 0.0069
166 PULMONARY TOXICITY 49 0.0069
167 CHOLESTASIS 133 0.0069
168 HEPATITIS TOXIC 18 0.0069
169 PRODUCT PRESCRIBING ISSUE 149 0.0068
170 WOUND DEHISCENCE 23 0.0068
171 MENTAL STATUS CHANGES 189 0.0068
172 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 60 0.0068
173 HEPATITIS FULMINANT 20 0.0067
174 HYPERLACTACIDAEMIA 18 0.0067
175 ASPERGILLUS INFECTION 44 0.0067
176 HEPATOSPLENOMEGALY 17 0.0066
177 HYPOALBUMINAEMIA 51 0.0066
178 JAUNDICE 176 0.0065
179 TYPE I HYPERSENSITIVITY 23 0.0065
180 TOXIC ENCEPHALOPATHY 33 0.0065
181 AUTOIMMUNE HAEMOLYTIC ANAEMIA 22 0.0064
182 PRODUCT USE COMPLAINT 101 0.0064
183 SMALL INTESTINAL OBSTRUCTION 78 0.0063
184 ENCEPHALITIS 43 0.0062
185 LUNG OPACITY 16 0.0061
186 BLOOD BILIRUBIN INCREASED 164 0.0061
187 SPUTUM DISCOLOURED 57 0.0060
188 INTERNATIONAL NORMALISED RATIO DECREASED 24 0.0059
189 HAEMORRHAGIC DIATHESIS 21 0.0059
190 DISSEMINATED INTRAVASCULAR COAGULATION 83 0.0059
191 BACTERAEMIA 69 0.0058
192 ANAL INCONTINENCE 52 0.0058
193 PSEUDOMONAS INFECTION 49 0.0057
194 LYME DISEASE 19 0.0057
195 MIXED LIVER INJURY 17 0.0056
196 END STAGE RENAL DISEASE 103 0.0056
197 INTERNAL HAEMORRHAGE 64 0.0056
198 ENTEROCOCCAL INFECTION 27 0.0056
199 MALNUTRITION 62 0.0055
200 IRON DEFICIENCY ANAEMIA 51 0.0055
201 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 21 0.0055
202 DEAFNESS NEUROSENSORY 18 0.0055
203 NEUROLOGICAL SYMPTOM 31 0.0054
204 EOSINOPHIL COUNT INCREASED 45 0.0054
205 DEPRESSIVE SYMPTOM 19 0.0054
206 JAUNDICE CHOLESTATIC 19 0.0054
207 BLOOD SODIUM DECREASED 101 0.0054
208 HAEMOPTYSIS 149 0.0053
209 DRUG INTOLERANCE 511 0.0053
210 CONFUSIONAL STATE 849 0.0052
211 TRANSAMINASES INCREASED 116 0.0052
212 CYTOMEGALOVIRUS INFECTION REACTIVATION 23 0.0052
213 DEATH 4467 0.0052
214 CLOSTRIDIUM DIFFICILE INFECTION 113 0.0052
215 ABSCESS LIMB 22 0.0052
216 UMBILICAL HERNIA 24 0.0051
217 ACUTE KIDNEY INJURY 784 0.0051
218 POLYARTHRITIS 27 0.0051
219 INCONTINENCE 54 0.0051
220 THROMBOTIC THROMBOCYTOPENIC PURPURA 18 0.0051
221 ACUTE RESPIRATORY FAILURE 98 0.0051
222 CANDIDA INFECTION 86 0.0051
223 SUSPECTED OFF LABEL USE 23 0.0051
224 NEPHROPATHY TOXIC 57 0.0051
225 DIALYSIS 72 0.0051
226 FREQUENT BOWEL MOVEMENTS 137 0.0051
227 RECALLED PRODUCT ADMINISTERED 48 0.0050
228 HEPATITIS 127 0.0050
229 ORGAN FAILURE 20 0.0050
230 ARTHRITIS INFECTIVE 23 0.0050
231 DYSLIPIDAEMIA 25 0.0049
232 ABDOMINAL DISTENSION 513 0.0049
233 DISEASE RECURRENCE 231 0.0049
234 MUCOUS STOOLS 24 0.0048
235 SKIN ODOUR ABNORMAL 19 0.0048
236 HAEMOLYSIS 37 0.0048
237 PRODUCT AVAILABILITY ISSUE 109 0.0048
238 TERMINAL STATE 32 0.0048
239 LOW BIRTH WEIGHT BABY 38 0.0048
240 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 37 0.0048
241 PSYCHIATRIC SYMPTOM 35 0.0047
242 VASCULITIS 55 0.0047
243 PNEUMONIA BACTERIAL 43 0.0047
244 TREATMENT FAILURE 388 0.0047
245 PRODUCT USE IN UNAPPROVED INDICATION 1159 0.0047
246 OLIGURIA 29 0.0047
247 LIVER INJURY 114 0.0046
248 HYPERURICAEMIA 19 0.0046
249 VIRAL MUTATION IDENTIFIED 17 0.0046
250 STAPHYLOCOCCAL INFECTION 152 0.0046
251 PRODUCT PRESCRIBING ERROR 109 0.0046
252 RENAL FAILURE 605 0.0046
253 OESOPHAGEAL CANDIDIASIS 18 0.0045
254 HEPATIC NECROSIS 17 0.0045
255 PULMONARY MASS 67 0.0045
256 TOXIC EPIDERMAL NECROLYSIS 68 0.0045
257 HEPATITIS C 54 0.0045
258 QUALITY OF LIFE DECREASED 60 0.0045
259 CACHEXIA 23 0.0045
260 IRON DEFICIENCY 20 0.0044
261 ABNORMAL FAECES 36 0.0044
262 RHINOVIRUS INFECTION 17 0.0044
263 PROTHROMBIN TIME PROLONGED 26 0.0043
264 MENINGITIS 29 0.0043
265 CHROMATURIA 98 0.0043
266 PNEUMONIA FUNGAL 17 0.0043
267 AUTOIMMUNE DISORDER 42 0.0043
268 SKIN HYPERPIGMENTATION 37 0.0043
269 SHOCK HAEMORRHAGIC 35 0.0043
270 CONDITION AGGRAVATED 1302 0.0043
271 DIARRHOEA HAEMORRHAGIC 40 0.0043
272 ANAL ABSCESS 23 0.0043
273 FAILURE TO THRIVE 22 0.0042
274 ABDOMINAL TENDERNESS 21 0.0042
275 HEPATIC PAIN 18 0.0042
276 GENERALISED OEDEMA 52 0.0042
277 DERMATITIS EXFOLIATIVE 21 0.0042
278 ATRIOVENTRICULAR BLOCK COMPLETE 28 0.0042
279 PURPURA 37 0.0042
280 HAEMATEMESIS 106 0.0042
281 FISTULA 47 0.0042
282 DRUG ERUPTION 74 0.0042
283 SERUM FERRITIN INCREASED 22 0.0042
284 DEFAECATION URGENCY 29 0.0041
285 NERVE INJURY 46 0.0041
286 DIVERTICULUM INTESTINAL 18 0.0041
287 LUNG INFILTRATION 36 0.0041
288 SEPTIC SHOCK 177 0.0041
289 DEAFNESS 106 0.0040
290 LYMPHOPENIA 57 0.0040
291 CEREBRAL ATROPHY 16 0.0040
292 ESCHERICHIA INFECTION 33 0.0040
293 AZOTAEMIA 16 0.0040
294 HEPATITIS ACUTE 26 0.0040
295 BLOOD URIC ACID INCREASED 23 0.0040
296 PRODUCTIVE COUGH 190 0.0040
297 HEPATOMEGALY 39 0.0040
298 ACUTE RESPIRATORY DISTRESS SYNDROME 70 0.0040
299 ORAL CANDIDIASIS 52 0.0039
300 FOETAL GROWTH RESTRICTION 24 0.0039
301 HUMERUS FRACTURE 19 0.0039
302 ILL-DEFINED DISORDER 239 0.0039
303 AGRANULOCYTOSIS 73 0.0039
304 ARTHRITIS BACTERIAL 16 0.0039
305 BRONCHOPULMONARY ASPERGILLOSIS 30 0.0039
306 PERITONITIS BACTERIAL 39 0.0039
307 STAPHYLOCOCCAL SEPSIS 19 0.0038
308 HALLUCINATIONS, MIXED 16 0.0038
309 SEROTONIN SYNDROME 73 0.0038
310 BRAIN OEDEMA 48 0.0038
311 GASTROINTESTINAL INFECTION 34 0.0038
312 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 111 0.0038
313 BOWEL MOVEMENT IRREGULARITY 29 0.0038
314 BLOOD ALBUMIN DECREASED 30 0.0038
315 LEUKOPENIA 188 0.0038
316 FLATULENCE 213 0.0038
317 THROMBOCYTOPENIA 420 0.0038
318 GRAFT VERSUS HOST DISEASE 27 0.0038
319 FAECES DISCOLOURED 81 0.0037
320 LACTIC ACIDOSIS 120 0.0037
321 MYOPATHY 32 0.0037
322 PANCYTOPENIA 207 0.0037
323 LEUKOCYTOSIS 67 0.0037
324 ELECTROLYTE IMBALANCE 43 0.0037
325 BACTERIAL INFECTION 69 0.0037
326 HEPATIC FUNCTION ABNORMAL 138 0.0037
327 FLUID RETENTION 187 0.0037
328 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 20 0.0037
329 LOCALISED OEDEMA 17 0.0037
330 TOXIC SKIN ERUPTION 37 0.0037
331 OSTEOMYELITIS 66 0.0036
332 LUPUS-LIKE SYNDROME 33 0.0036
333 MALABSORPTION 19 0.0036
334 METABOLIC ACIDOSIS 115 0.0036
335 SECRETION DISCHARGE 45 0.0036
336 THERAPY NON-RESPONDER 161 0.0036
337 NYSTAGMUS 19 0.0036
338 FLUID OVERLOAD 52 0.0036
339 INCOHERENT 23 0.0035
340 GASTROINTESTINAL MOTILITY DISORDER 19 0.0035
341 PRODUCT USE ISSUE 667 0.0035
342 SUBCUTANEOUS ABSCESS 17 0.0035
343 STATUS EPILEPTICUS 40 0.0035
344 DRUG SPECIFIC ANTIBODY PRESENT 23 0.0035
345 CROHN'S DISEASE 24 0.0035
346 HYPOGAMMAGLOBULINAEMIA 23 0.0035
347 CARDIAC VALVE DISEASE 20 0.0035
348 RECTAL HAEMORRHAGE 149 0.0035
349 ENTEROCOLITIS 20 0.0035
350 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 33 0.0035
351 INTESTINAL ISCHAEMIA 19 0.0034
352 UNINTENDED PREGNANCY 36 0.0034
353 FAECES SOFT 25 0.0034
354 ORGANISING PNEUMONIA 17 0.0034
355 HEPATIC ENZYME ABNORMAL 17 0.0034
356 PANCREATITIS 180 0.0034
357 RHABDOMYOLYSIS 142 0.0034
358 ACIDOSIS 26 0.0034
359 ANORECTAL DISCOMFORT 18 0.0034
360 SEPSIS 376 0.0034
361 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0034
362 ANAL FISSURE 18 0.0034
363 MEDICATION RESIDUE PRESENT 16 0.0033
364 CHRONIC KIDNEY DISEASE 254 0.0033
365 ABSCESS 53 0.0033
366 HYPONATRAEMIA 187 0.0033
367 HEPATOCELLULAR INJURY 47 0.0033
368 UPPER LIMB FRACTURE 66 0.0033
369 AUTOIMMUNE HEPATITIS 23 0.0033
370 INTENTIONAL PRODUCT USE ISSUE 289 0.0033
371 LYMPHADENOPATHY 116 0.0033
372 GASTROINTESTINAL PAIN 36 0.0033
373 PETECHIAE 34 0.0033
374 HAEMORRHOIDS 63 0.0032
375 BLOOD POTASSIUM DECREASED 97 0.0032
376 NODULE 42 0.0032
377 ATELECTASIS 31 0.0032
378 PANCREATITIS ACUTE 72 0.0032
379 PREMATURE DELIVERY 51 0.0032
380 DEVICE RELATED INFECTION 49 0.0032
381 RESPIRATORY FAILURE 232 0.0032
382 BLOOD ALKALINE PHOSPHATASE INCREASED 79 0.0032
383 COMPRESSION FRACTURE 17 0.0032
384 GASTROINTESTINAL DISORDER 284 0.0032
385 HIATUS HERNIA 41 0.0032
386 RENAL IMPAIRMENT 265 0.0032
387 CARDIAC FAILURE ACUTE 21 0.0031
388 INTENTIONAL UNDERDOSE 23 0.0031
389 NEUROTOXICITY 55 0.0031
390 ULCER HAEMORRHAGE 21 0.0031
391 PNEUMOTHORAX 49 0.0031
392 PLEURAL EFFUSION 188 0.0031
393 INTERNATIONAL NORMALISED RATIO INCREASED 88 0.0031
394 GENERALISED TONIC-CLONIC SEIZURE 51 0.0031
395 APHONIA 43 0.0031
396 DISORIENTATION 122 0.0031
397 THERAPY PARTIAL RESPONDER 48 0.0031
398 POST PROCEDURAL INFECTION 25 0.0031
399 TENDERNESS 32 0.0031
400 ABDOMINAL PAIN 711 0.0031
401 TRANSFUSION 32 0.0031
402 NECROSIS 17 0.0031
403 ASPARTATE AMINOTRANSFERASE INCREASED 162 0.0030
404 PEMPHIGOID 23 0.0030
405 CATATONIA 16 0.0030
406 HIP FRACTURE 98 0.0030
407 SEASONAL ALLERGY 43 0.0030
408 LYMPHOEDEMA 21 0.0030
409 LARGE INTESTINE POLYP 21 0.0030
410 BLOOD POTASSIUM INCREASED 49 0.0030
411 INTENTIONAL DOSE OMISSION 86 0.0030
412 BLOOD MAGNESIUM DECREASED 26 0.0030
413 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
414 RENAL DISORDER 139 0.0030
415 HAEMODIALYSIS 25 0.0030
416 COLITIS ISCHAEMIC 20 0.0030
417 ANAEMIA 565 0.0030
418 DRUG LEVEL INCREASED 49 0.0030
419 FEEDING DISORDER 60 0.0030
420 CHEILITIS 16 0.0030
421 PERICARDIAL EFFUSION 68 0.0029
422 CELLULITIS 148 0.0029
423 ASPIRATION 32 0.0029
424 OEDEMA 158 0.0029
425 SHOCK 67 0.0029
426 UNRESPONSIVE TO STIMULI 75 0.0029
427 RENAL CYST 23 0.0029
428 TINNITUS 133 0.0029
429 DYSPHONIA 169 0.0029
430 GASTRIC HAEMORRHAGE 33 0.0029
431 IMPAIRED GASTRIC EMPTYING 39 0.0029
432 HYPOKALAEMIA 132 0.0029
433 CARDIOGENIC SHOCK 41 0.0029
434 COMA 136 0.0029
435 HYPOPHAGIA 73 0.0029
436 IMMUNOSUPPRESSION 25 0.0028
437 DELIRIUM 98 0.0028
438 HYPERKALAEMIA 99 0.0028
439 IMMUNODEFICIENCY 42 0.0028
440 PULMONARY HAEMORRHAGE 22 0.0028
441 BRAIN FOG 44 0.0028
442 HAEMATOCHEZIA 153 0.0028
443 OFF LABEL USE 2423 0.0028
444 REFUSAL OF TREATMENT BY PATIENT 18 0.0028
445 POLYP 18 0.0027
446 C-REACTIVE PROTEIN INCREASED 100 0.0027
447 OESOPHAGITIS 30 0.0027
448 HEPATIC STEATOSIS 51 0.0027
449 HYPERTENSIVE CRISIS 30 0.0027
450 ALANINE AMINOTRANSFERASE INCREASED 165 0.0027
451 IMPAIRED QUALITY OF LIFE 38 0.0026
452 INFUSION SITE PAIN 34 0.0026
453 ADRENAL INSUFFICIENCY 32 0.0026
454 NEPHROTIC SYNDROME 18 0.0026
455 SKIN LESION 72 0.0026
456 HAEMATOCRIT DECREASED 52 0.0026
457 TRANSPLANT REJECTION 21 0.0026
458 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
459 DIARRHOEA 1683 0.0026
460 BEDRIDDEN 34 0.0026
461 HYPOMAGNESAEMIA 36 0.0026
462 RENAL FAILURE ACUTE 109 0.0026
463 CEREBRAL DISORDER 19 0.0026
464 VITAMIN D DEFICIENCY 25 0.0026
465 GASTROINTESTINAL HAEMORRHAGE 214 0.0026
466 ANURIA 22 0.0026
467 OEDEMA PERIPHERAL 310 0.0025
468 LETHARGY 146 0.0025
469 RESPIRATORY DISTRESS 70 0.0025
470 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 26 0.0025
471 POSTOPERATIVE WOUND INFECTION 17 0.0025
472 HYPOTHYROIDISM 80 0.0025
473 IMMUNE SYSTEM DISORDER 33 0.0025
474 ENTERITIS 16 0.0025
475 HYPOXIA 88 0.0025
476 VISUAL FIELD DEFECT 18 0.0025
477 EMPHYSEMA 25 0.0025
478 LIVER FUNCTION TEST ABNORMAL 72 0.0025
479 GOUT 44 0.0024
480 PYREXIA 848 0.0024
481 APHTHOUS ULCER 19 0.0024
482 RETCHING 52 0.0024
483 RIB FRACTURE 50 0.0024
484 POLYNEUROPATHY 29 0.0024
485 TORSADE DE POINTES 19 0.0024
486 URINARY TRACT INFECTION 408 0.0024
487 ULCER 38 0.0024
488 NEUTROPENIA 324 0.0024
489 ABDOMINAL PAIN UPPER 490 0.0024
490 ERUCTATION 46 0.0024
491 TENDON PAIN 18 0.0024
492 GENERAL PHYSICAL HEALTH DETERIORATION 275 0.0024
493 INFUSION SITE ERYTHEMA 20 0.0024
494 COLITIS ULCERATIVE 106 0.0024
495 SKIN PLAQUE 20 0.0024
496 DEMENTIA 66 0.0024
497 ALTERED STATE OF CONSCIOUSNESS 51 0.0024
498 DEHYDRATION 314 0.0024
499 PULMONARY OEDEMA 105 0.0023
500 HAEMORRHAGE INTRACRANIAL 35 0.0023
501 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 122 0.0023
502 LIVER FUNCTION TEST INCREASED 50 0.0023
503 NIGHT SWEATS 75 0.0023
504 GASTRITIS 61 0.0023
505 DYSPNOEA EXERTIONAL 87 0.0023
506 EATING DISORDER 49 0.0023
507 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
508 BLOOD CREATINE PHOSPHOKINASE INCREASED 66 0.0023
509 RENAL INJURY 68 0.0023
510 FACE OEDEMA 38 0.0023
511 WRIST FRACTURE 27 0.0023
512 FUNGAL INFECTION 75 0.0022
513 FALL 738 0.0022
514 REBOUND EFFECT 25 0.0022
515 PNEUMONIA 715 0.0022
516 CYTOPENIA 27 0.0022
517 POLYURIA 18 0.0022
518 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
519 CARDIAC MURMUR 19 0.0022
520 CHOLELITHIASIS 72 0.0022
521 POST PROCEDURAL COMPLICATION 42 0.0022
522 COUGH 613 0.0022
523 PELVIC FRACTURE 17 0.0022
524 BLOOD CREATININE INCREASED 142 0.0022
525 INCREASED TENDENCY TO BRUISE 20 0.0022
526 HERNIA 42 0.0022
527 CYTOMEGALOVIRUS INFECTION 36 0.0022
528 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
529 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
530 LUNG DISORDER 106 0.0022
531 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
532 STEVENS-JOHNSON SYNDROME 48 0.0022
533 BLOOD UREA INCREASED 36 0.0021
534 WEIGHT DECREASED 600 0.0021
535 INTESTINAL OBSTRUCTION 81 0.0021
536 RASH ERYTHEMATOUS 102 0.0021
537 TEMPERATURE INTOLERANCE 22 0.0021
538 HEPATIC ENZYME INCREASED 145 0.0021
539 HEMIPARESIS 36 0.0021
540 SQUAMOUS CELL CARCINOMA 20 0.0021
541 CEREBRAL HAEMORRHAGE 76 0.0021
542 HEAD INJURY 67 0.0021
543 PULMONARY HYPERTENSION 44 0.0021
544 INFLAMMATION 109 0.0021
545 ECONOMIC PROBLEM 32 0.0021
546 VOMITING 991 0.0021
547 DYSPHAGIA 200 0.0021
548 WEIGHT FLUCTUATION 22 0.0021
549 DECUBITUS ULCER 17 0.0021
550 MULTI-ORGAN FAILURE 36 0.0021
551 PYELONEPHRITIS 18 0.0021
552 FOOD ALLERGY 16 0.0021
553 DISEASE PROGRESSION 245 0.0021
554 ANKLE FRACTURE 32 0.0021
555 TACHYPNOEA 28 0.0021
556 SLUGGISHNESS 21 0.0021
557 MEMORY IMPAIRMENT 282 0.0021
558 PULMONARY CONGESTION 27 0.0020
559 MELAENA 45 0.0020
560 OSTEOPENIA 31 0.0020
561 ILLNESS 209 0.0020
562 ROTATOR CUFF SYNDROME 26 0.0020
563 NEUROPATHY PERIPHERAL 192 0.0020
564 CHOKING 39 0.0020
565 BLOOD DISORDER 16 0.0020
566 GASTROOESOPHAGEAL REFLUX DISEASE 160 0.0020
567 AMNESIA 129 0.0020
568 MENTAL IMPAIRMENT 48 0.0020
569 ABDOMINAL PAIN LOWER 50 0.0020
570 HYPOTHERMIA 20 0.0020
571 DECREASED APPETITE 456 0.0020
572 NAUSEA 1550 0.0020
573 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
574 HAEMOGLOBIN DECREASED 200 0.0019
575 GAIT INABILITY 65 0.0019
576 MITRAL VALVE INCOMPETENCE 22 0.0019
577 EPISTAXIS 145 0.0019
578 MUSCULOSKELETAL CHEST PAIN 30 0.0019
579 BLOOD IRON DECREASED 23 0.0019
580 THINKING ABNORMAL 36 0.0019
581 CHOLECYSTITIS 23 0.0019
582 ERYTHEMA MULTIFORME 18 0.0019
583 DYSURIA 71 0.0019
584 COLITIS 73 0.0019
585 VIRAL INFECTION 64 0.0019
586 PERIPHERAL SWELLING 295 0.0019
587 BACK DISORDER 31 0.0019
588 ABDOMINAL DISCOMFORT 319 0.0019
589 NEPHROLITHIASIS 87 0.0019
590 HYPERSOMNIA 54 0.0019
591 OROPHARYNGEAL DISCOMFORT 17 0.0019
592 SURGERY 110 0.0019
593 HYPOGLYCAEMIA 91 0.0019
594 DISABILITY 37 0.0019
595 DRY THROAT 19 0.0019
596 SCAR 32 0.0019
597 ASTHENIA 702 0.0019
598 HYPERCALCAEMIA 23 0.0019
599 SKIN REACTION 26 0.0018
600 HYPERLIPIDAEMIA 22 0.0018
601 PROTEINURIA 35 0.0018
602 DERMATITIS ALLERGIC 23 0.0018
603 GASTROENTERITIS VIRAL 33 0.0018
604 PREMATURE BABY 55 0.0018
605 NERVOUS SYSTEM DISORDER 57 0.0018
606 DRUG PRESCRIBING ERROR 35 0.0018
607 NEPHROPATHY 17 0.0018
608 LOCALISED INFECTION 44 0.0018
609 DRUG INEFFECTIVE 2392 0.0018
610 NOCTURIA 22 0.0018
611 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 87 0.0018
612 CONSTIPATION 394 0.0018
613 RESPIRATORY DISORDER 54 0.0018
614 SEIZURE 208 0.0018
615 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
616 CARDIOMEGALY 22 0.0018
617 SPINAL OPERATION 22 0.0018
618 CARDIAC ARREST 147 0.0018
619 ORTHOSTATIC HYPOTENSION 31 0.0018
620 ILEUS 22 0.0018
621 PRESCRIBED OVERDOSE 34 0.0018
622 BRONCHOSPASM 25 0.0018
623 TENDONITIS 27 0.0017
624 SWELLING 163 0.0017
625 SKIN DISCOLOURATION 80 0.0017
626 SKIN ULCER 45 0.0017
627 DRUG DOSE OMISSION 287 0.0017
628 UNEVALUABLE EVENT 131 0.0017
629 PULMONARY ARTERIAL HYPERTENSION 25 0.0017
630 EYELID OEDEMA 20 0.0017
631 HYPOTENSION 345 0.0017
632 CARDIAC FAILURE 138 0.0017
633 THROAT IRRITATION 77 0.0017
634 RESTLESS LEGS SYNDROME 31 0.0017
635 DYSARTHRIA 64 0.0017
636 INTESTINAL PERFORATION 19 0.0017
637 COGNITIVE DISORDER 79 0.0017
638 PNEUMONITIS 46 0.0017
639 ATAXIA 20 0.0017
640 OROPHARYNGEAL PAIN 156 0.0017
641 KIDNEY INFECTION 33 0.0017
642 PNEUMONIA ASPIRATION 42 0.0017
643 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 119 0.0017
644 INFECTION 241 0.0017
645 DYSPEPSIA 163 0.0017
646 OXYGEN SATURATION DECREASED 93 0.0017
647 THERAPEUTIC RESPONSE UNEXPECTED 74 0.0016
648 SPINAL FRACTURE 33 0.0016
649 LOSS OF CONSCIOUSNESS 211 0.0016
650 CHILLS 193 0.0016
651 GASTROENTERITIS 24 0.0016
652 EXPOSURE DURING PREGNANCY 102 0.0016
653 TREMOR 272 0.0016
654 INFLAMMATORY BOWEL DISEASE 16 0.0016
655 DISTURBANCE IN ATTENTION 88 0.0016
656 SCIATICA 26 0.0016
657 DIVERTICULITIS 45 0.0016
658 DERMATITIS 34 0.0016
659 RASH GENERALISED 42 0.0016
660 LIMB INJURY 44 0.0016
661 SINUS TACHYCARDIA 23 0.0016
662 LYMPHOMA 25 0.0016
663 THERAPEUTIC PRODUCT EFFECT DECREASED 72 0.0016
664 OSTEOPOROSIS 66 0.0016
665 PLATELET COUNT DECREASED 171 0.0016
666 TOXICITY TO VARIOUS AGENTS 269 0.0016
667 CIRCULATORY COLLAPSE 27 0.0016
668 BALANCE DISORDER 137 0.0016
669 IMPAIRED DRIVING ABILITY 18 0.0016
670 BLOOD COUNT ABNORMAL 24 0.0016
671 DYSPNOEA 893 0.0016
672 PRURITUS 606 0.0016
673 BONE MARROW FAILURE 32 0.0016
674 PRURITUS GENERALISED 34 0.0016
675 MALAISE 687 0.0016
676 MENTAL DISORDER 68 0.0016
677 LOWER LIMB FRACTURE 30 0.0016
678 DIABETES MELLITUS 119 0.0016
679 ATRIAL FIBRILLATION 152 0.0016
680 ANHEDONIA 41 0.0016
681 APHASIA 47 0.0016
682 CARDIOMYOPATHY 23 0.0016
683 SKIN HAEMORRHAGE 23 0.0016
684 HEART RATE IRREGULAR 35 0.0015
685 PERITONITIS 32 0.0015
686 GASTRIC DISORDER 53 0.0015
687 TACHYCARDIA 137 0.0015
688 BLOOD PRESSURE FLUCTUATION 37 0.0015
689 FATIGUE 1195 0.0015
690 CYST 19 0.0015
691 MYELOSUPPRESSION 55 0.0015
692 BLINDNESS 62 0.0015
693 URINARY INCONTINENCE 45 0.0015
694 PRODUCT DOSE OMISSION IN ERROR 43 0.0015
695 DEPRESSED LEVEL OF CONSCIOUSNESS 60 0.0015
696 DIZZINESS 756 0.0015
697 HYPOKINESIA 22 0.0015
698 MYOCLONUS 18 0.0015
699 HAEMATOMA 39 0.0015
700 SKIN DISORDER 50 0.0015
701 RASH PRURITIC 81 0.0015
702 SCAB 17 0.0015
703 POOR QUALITY SLEEP 32 0.0015
704 RHINORRHOEA 96 0.0015
705 GASTRIC ULCER 28 0.0015
706 HALLUCINATION 111 0.0015
707 BACK INJURY 16 0.0015
708 SUBDURAL HAEMATOMA 21 0.0015
709 RASH 638 0.0015
710 MUSCLE SPASMS 267 0.0015
711 INTERSTITIAL LUNG DISEASE 70 0.0014
712 CYSTITIS 46 0.0014
713 SYNOVITIS 26 0.0014
714 ANKYLOSING SPONDYLITIS 19 0.0014
715 DYSSTASIA 42 0.0014
716 HIP ARTHROPLASTY 22 0.0014
717 RED BLOOD CELL COUNT DECREASED 41 0.0014
718 HYPERGLYCAEMIA 52 0.0014
719 FOOT FRACTURE 27 0.0014
720 LABORATORY TEST ABNORMAL 42 0.0014
721 BODY TEMPERATURE INCREASED 29 0.0014
722 MUSCLE ATROPHY 18 0.0014
723 CONTRAINDICATED PRODUCT ADMINISTERED 43 0.0014
724 SLEEP APNOEA SYNDROME 27 0.0014
725 BLOOD PRESSURE DECREASED 94 0.0014
726 MICTURITION URGENCY 16 0.0014
727 WEIGHT INCREASED 313 0.0014
728 GINGIVAL BLEEDING 19 0.0014
729 HAEMORRHAGE 144 0.0014
730 COVID-19 241 0.0014
731 CHEST DISCOMFORT 140 0.0014
732 TOOTH INFECTION 18 0.0014
733 MYALGIA 232 0.0014
734 HUNGER 19 0.0014
735 UPPER RESPIRATORY TRACT INFECTION 63 0.0014
736 PRESYNCOPE 33 0.0014
737 SOMNOLENCE 273 0.0014
738 HEAD DISCOMFORT 24 0.0014
739 PSYCHOTIC DISORDER 40 0.0014
740 DIPLOPIA 35 0.0013
741 ADVERSE DRUG REACTION 121 0.0013
742 CARDIAC FAILURE CONGESTIVE 108 0.0013
743 INCORRECT PRODUCT ADMINISTRATION DURATION 29 0.0013
744 BRONCHITIS 99 0.0013
745 MANIA 22 0.0013
746 SINUS CONGESTION 18 0.0013
747 MOUTH ULCERATION 28 0.0013
748 HALLUCINATION, VISUAL 28 0.0013
749 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
750 HEADACHE 829 0.0013
751 INSOMNIA 352 0.0013
752 SPEECH DISORDER 69 0.0013
753 TYPE 2 DIABETES MELLITUS 44 0.0013
754 PLATELET COUNT INCREASED 17 0.0013
755 BACK PAIN 302 0.0013
756 FEELING ABNORMAL 311 0.0013
757 ARTHRITIS 102 0.0013
758 MUSCULAR WEAKNESS 147 0.0013
759 JOINT SWELLING 156 0.0013
760 LUNG INFECTION 20 0.0013
761 HAEMATURIA 44 0.0013
762 VISUAL IMPAIRMENT 159 0.0013
763 CHEST PAIN 237 0.0013
764 DEVICE OCCLUSION 18 0.0013
765 POLLAKIURIA 53 0.0013
766 VISUAL ACUITY REDUCED 42 0.0013
767 MUSCULOSKELETAL PAIN 66 0.0013
768 URINARY RETENTION 42 0.0013
769 GAIT DISTURBANCE 240 0.0013
770 ACCIDENTAL UNDERDOSE 18 0.0012
771 ANOREXIA 16 0.0012
772 GALLBLADDER DISORDER 22 0.0012
773 FEMUR FRACTURE 38 0.0012
774 HYPERSENSITIVITY 226 0.0012
775 SINUS DISORDER 24 0.0012
776 BLOOD URINE PRESENT 23 0.0012
777 VENTRICULAR TACHYCARDIA 20 0.0012
778 BLISTER 68 0.0012
779 BONE DISORDER 22 0.0012
780 DEEP VEIN THROMBOSIS 78 0.0012
781 VERTIGO 73 0.0012
782 MOBILITY DECREASED 86 0.0012
783 RESPIRATORY TRACT CONGESTION 19 0.0012
784 HALLUCINATION, AUDITORY 19 0.0012
785 URTICARIA 200 0.0012
786 FULL BLOOD COUNT DECREASED 24 0.0012
787 RESPIRATORY TRACT INFECTION 31 0.0012
788 ACUTE MYOCARDIAL INFARCTION 35 0.0012
789 NO ADVERSE EVENT 215 0.0012
790 HERPES ZOSTER 68 0.0012
791 WOUND 33 0.0012
792 PRODUCT DOSE OMISSION ISSUE 346 0.0012
793 THIRST 21 0.0012
794 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
795 PAIN IN JAW 33 0.0012
796 HYPOCALCAEMIA 22 0.0012
797 HYPERTENSION 246 0.0012
798 ORAL PAIN 26 0.0012
799 DRUG EFFECT INCOMPLETE 42 0.0012
800 NEOPLASM MALIGNANT 77 0.0012
801 HEART RATE INCREASED 114 0.0011
802 RESTLESSNESS 42 0.0011
803 ARTHRALGIA 476 0.0011
804 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 204 0.0011
805 WHEEZING 67 0.0011
806 OBESITY 18 0.0011
807 ORAL HERPES 22 0.0011
808 PANIC ATTACK 41 0.0011
809 INFLUENZA 125 0.0011
810 FRACTURE 21 0.0011
811 MUSCULOSKELETAL STIFFNESS 97 0.0011
812 BLOOD PRESSURE ABNORMAL 22 0.0011
813 NASAL CONGESTION 65 0.0011
814 SWELLING FACE 72 0.0011
815 ROAD TRAFFIC ACCIDENT 46 0.0011
816 APATHY 16 0.0011
817 EYE DISORDER 36 0.0011
818 HYPOACUSIS 47 0.0011
819 NECK PAIN 61 0.0011
820 SLEEP DISORDER 77 0.0011
821 RASH MACULAR 38 0.0011
822 ANAPHYLACTIC SHOCK 28 0.0011
823 VISION BLURRED 149 0.0011
824 ADVERSE EVENT 100 0.0011
825 CONTUSION 104 0.0011
826 EAR PAIN 21 0.0011
827 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
828 PARAESTHESIA 169 0.0011
829 BLOOD PRESSURE INCREASED 164 0.0011
830 PERICARDITIS 18 0.0011
831 NEURALGIA 26 0.0011
832 ANXIETY 304 0.0011
833 ANAPHYLACTIC REACTION 59 0.0011
834 PALLOR 29 0.0011
835 DISCOMFORT 65 0.0011
836 PHOTOPHOBIA 20 0.0011
837 DYSGEUSIA 79 0.0011
838 BLOOD GLUCOSE DECREASED 51 0.0011
839 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
840 FOETAL EXPOSURE DURING PREGNANCY 86 0.0011
841 BURNING SENSATION 74 0.0011
842 CARDIO-RESPIRATORY ARREST 44 0.0011
843 AGITATION 77 0.0010
844 DRY MOUTH 85 0.0010
845 PAIN 642 0.0010
846 CATARACT 62 0.0010
847 CARDIAC DISORDER 97 0.0010
848 THROAT TIGHTNESS 28 0.0010
849 ABNORMAL BEHAVIOUR 41 0.0010
850 LIMB DISCOMFORT 32 0.0010
851 BLOOD GLUCOSE ABNORMAL 19 0.0010
852 BASAL CELL CARCINOMA 16 0.0010
853 MIDDLE INSOMNIA 19 0.0010
854 FEELING COLD 28 0.0010
855 DEPRESSION 228 0.0010
856 KNEE ARTHROPLASTY 21 0.0010
857 EYE SWELLING 37 0.0010
858 EXPIRED PRODUCT ADMINISTERED 33 0.0010
859 THERAPEUTIC RESPONSE DECREASED 60 0.0010
860 MATERNAL EXPOSURE DURING PREGNANCY 88 0.0010
861 SINUSITIS 101 0.0010
862 IMPAIRED WORK ABILITY 21 0.0010
863 CEREBRAL INFARCTION 24 0.0010
864 RESPIRATORY ARREST 27 0.0010
865 ANGINA PECTORIS 28 0.0010
866 INFLUENZA LIKE ILLNESS 80 0.0010
867 ABASIA 24 0.0010
868 CONJUNCTIVITIS 18 0.0010
869 PULMONARY EMBOLISM 92 0.0010
870 LYMPHOCYTE COUNT DECREASED 17 0.0010
871 LIP SWELLING 32 0.0010
872 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
873 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
874 THROMBOSIS 77 0.0010
875 ERYTHEMA 195 0.0009
876 TRANSIENT ISCHAEMIC ATTACK 32 0.0009
877 CEREBROVASCULAR ACCIDENT 160 0.0009
878 HYPOAESTHESIA 141 0.0009
879 INCREASED APPETITE 18 0.0009
880 STOMATITIS 57 0.0009
881 HEART RATE DECREASED 33 0.0009
882 SYNCOPE 94 0.0009
883 TOOTHACHE 17 0.0009
884 NERVOUSNESS 49 0.0009
885 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 190 0.0009
886 RASH PAPULAR 21 0.0009
887 ARTHROPATHY 52 0.0009
888 SKIN CANCER 20 0.0009
889 OSTEOARTHRITIS 39 0.0009
890 EPILEPSY 28 0.0009
891 ANGIOEDEMA 40 0.0009
892 MIGRAINE 86 0.0009
893 IRRITABILITY 54 0.0009
894 PAIN IN EXTREMITY 263 0.0009
895 PAIN OF SKIN 24 0.0009
896 BRADYCARDIA 47 0.0009
897 NASOPHARYNGITIS 163 0.0009
898 PALPITATIONS 103 0.0009
899 WHITE BLOOD CELL COUNT DECREASED 95 0.0009
900 EYE PAIN 49 0.0009
901 SKIN EXFOLIATION 73 0.0009
902 LACRIMATION INCREASED 26 0.0009
903 CRYING 31 0.0009
904 SUICIDAL IDEATION 78 0.0009
905 CYTOKINE RELEASE SYNDROME 17 0.0008
906 ACCIDENTAL OVERDOSE 31 0.0008
907 SNEEZING 19 0.0008
908 PRODUCT DOSE OMISSION 55 0.0008
909 PRODUCT ADMINISTRATION ERROR 17 0.0008
910 INTENTIONAL PRODUCT MISUSE 73 0.0008
911 CORONARY ARTERY DISEASE 25 0.0008
912 ARRHYTHMIA 39 0.0008
913 ECZEMA 43 0.0008
914 DRUG ADMINISTRATION ERROR 25 0.0008
915 FEBRILE NEUTROPENIA 54 0.0008
916 ANGER 27 0.0008
917 PSORIASIS 103 0.0008
918 NEUTROPHIL COUNT DECREASED 32 0.0008
919 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
920 LUNG NEOPLASM MALIGNANT 31 0.0008
921 INJURY 53 0.0008
922 EAR INFECTION 20 0.0008
923 DYSKINESIA 30 0.0007
924 MEDICATION ERROR 41 0.0007
925 SWOLLEN TONGUE 23 0.0007
926 BLOOD GLUCOSE INCREASED 137 0.0007
927 HYPERHIDROSIS 93 0.0007
928 AGEUSIA 18 0.0007
929 MOOD SWINGS 23 0.0007
930 PSORIATIC ARTHROPATHY 29 0.0007
931 FEAR 19 0.0007
932 IMPAIRED HEALING 23 0.0007
933 FLUSHING 71 0.0007
934 NIGHTMARE 24 0.0007
935 JOINT STIFFNESS 18 0.0007
936 BONE PAIN 40 0.0007
937 GYNAECOMASTIA 21 0.0007
938 MOOD ALTERED 18 0.0007
939 MOVEMENT DISORDER 21 0.0007
940 EMOTIONAL DISTRESS 79 0.0007
941 ABNORMAL DREAMS 18 0.0007
942 ASTHMA 72 0.0006
943 MYOCARDIAL INFARCTION 111 0.0006
944 DEPRESSED MOOD 33 0.0006
945 ERECTILE DYSFUNCTION 16 0.0006
946 PROCEDURAL PAIN 17 0.0006
947 MUCOSAL INFLAMMATION 16 0.0006
948 FEELING HOT 37 0.0006
949 DEVICE ISSUE 54 0.0006
950 INCORRECT DOSE ADMINISTERED 137 0.0006
951 UNDERDOSE 43 0.0006
952 WITHDRAWAL SYNDROME 24 0.0006
953 DRUG EFFECT DECREASED 30 0.0006
954 EMOTIONAL DISORDER 17 0.0006
955 HOT FLUSH 41 0.0005
956 BONE DENSITY DECREASED 17 0.0005
957 DEVICE LEAKAGE 23 0.0005
958 OCULAR HYPERAEMIA 25 0.0005
959 RHEUMATOID ARTHRITIS 59 0.0005
960 ALOPECIA 97 0.0005
961 DRY SKIN 60 0.0004
962 OVERDOSE 96 0.0004
963 EXTRA DOSE ADMINISTERED 18 0.0004
964 DRY EYE 22 0.0004
965 AGGRESSION 22 0.0004
966 VAGINAL HAEMORRHAGE 19 0.0004
967 DERMATITIS ATOPIC 23 0.0004
968 EYE IRRITATION 25 0.0004
969 SUICIDE ATTEMPT 26 0.0004
970 INFUSION RELATED REACTION 28 0.0004
971 CONVULSION 24 0.0004
972 PRODUCT SUBSTITUTION ISSUE 21 0.0004
973 BLOOD CHOLESTEROL INCREASED 17 0.0004
974 BREAST CANCER 33 0.0004
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
976 DRUG DOSE OMISSION BY DEVICE 26 0.0003
977 INJECTION SITE ERYTHEMA 40 0.0003
978 ACNE 24 0.0003
979 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
980 INJECTION SITE PAIN 92 0.0003
981 PRODUCT QUALITY ISSUE 40 0.0003
982 INJECTION SITE BRUISING 23 0.0003
983 DEVICE MALFUNCTION 20 0.0003
984 INJECTION SITE PRURITUS 19 0.0003
985 COMPLETED SUICIDE 23 0.0003
986 SKIN BURNING SENSATION 19 0.0003
987 INTENTIONAL OVERDOSE 17 0.0003
988 INJECTION SITE HAEMORRHAGE 20 0.0003
989 INJECTION SITE REACTION 16 0.0002
990 PRODUCT STORAGE ERROR 19 0.0002
991 DRUG WITHDRAWAL SYNDROME 19 0.0002
992 INJECTION SITE SWELLING 16 0.0002
993 DRUG DEPENDENCE 28 0.0002